|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.401
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.324
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.302
|
|
|
|
cerebellar granule cell precursor tangential migration
|
GO:0021935 |
1 |
0.281
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.269
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.245
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.244
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.239
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.235
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.230
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.210
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.210
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.204
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.201
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.195
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.195
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.194
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.193
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.191
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.190
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.190
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.182
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.181
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.176
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.176
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.169
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.169
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.166
|
Human |
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.166
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.164
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.159
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.158
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.156
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.153
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.152
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.148
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.148
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.146
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.145
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.143
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.142
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.141
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.134
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.134
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.133
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.130
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.129
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.128
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.128
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.127
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.125
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.122
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.121
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.119
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.116
|
Human |
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.116
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.116
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.114
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.114
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.114
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.111
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.109
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.105
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.104
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.104
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.103
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.102
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.102
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.100
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.099
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.099
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.099
|
Human |
|
|
neural tube closure
|
GO:0001843 |
90 |
0.098
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.097
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.097
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.097
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.096
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.095
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.095
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.095
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.095
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.090
|
Human |
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.089
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.089
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.089
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.088
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.088
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.088
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.087
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.086
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.086
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.086
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.085
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.085
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.085
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.083
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.082
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.082
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.081
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.081
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.081
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.079
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.078
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.078
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.077
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.077
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.077
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.077
|
|
|
|
gonadotrophin releasing hormone neuronal migration to the hypothalamus
|
GO:0021828 |
3 |
0.077
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.077
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.077
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.076
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.075
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.075
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.075
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.075
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.074
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.074
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.074
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.074
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.074
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.073
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.073
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.072
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.072
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.072
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.072
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.071
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.070
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.070
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.069
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.069
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.069
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.069
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.068
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.068
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.068
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.068
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.068
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.067
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.067
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.067
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.067
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.067
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.066
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.066
|
Human |
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.066
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.066
|
|
|
|
semaphorin plexin signaling pathway involved in bone trabecula morphogenesis
|
GO:1900220 |
2 |
0.066
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.065
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.065
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.064
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.064
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.064
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.063
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.063
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.062
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.062
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.062
|
|
|
|
branchiomotor neuron axon guidance
|
GO:0021785 |
7 |
0.061
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.061
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.061
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.061
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.061
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.061
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.060
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.060
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.060
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.059
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.059
|
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.058
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.058
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.058
|
Human |
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.057
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.057
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.057
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.057
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.057
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.056
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.055
|
Human |
|
|
t cell activation
|
GO:0042110 |
289 |
0.055
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.055
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.055
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.054
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.054
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.054
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.053
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.053
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.053
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.053
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.052
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.052
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.052
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.052
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.052
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.051
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.051
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.050
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.050
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.050
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.050
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.050
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.049
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.048
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.048
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.048
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.048
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.048
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.047
|
Human |
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.047
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.047
|
|
|
|
hypothalamus gonadotrophin releasing hormone neuron development
|
GO:0021888 |
4 |
0.046
|
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.045
|
|
|
|
chemorepulsion of branchiomotor axon
|
GO:0021793 |
1 |
0.045
|
|
|
|
positive regulation of macroautophagy
|
GO:0016239 |
3 |
0.045
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.044
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.044
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.044
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.044
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.044
|
|
|
|
cellular response to radiation
|
GO:0071478 |
28 |
0.044
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.043
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.043
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.043
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.043
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.042
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.042
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.042
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.041
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.041
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.041
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.040
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.040
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.040
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.040
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.040
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.039
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.039
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.039
|
|
|
|
facioacoustic ganglion development
|
GO:1903375 |
3 |
0.039
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.039
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.039
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.039
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.038
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.038
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.038
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.038
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
91 |
0.038
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.038
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.038
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.038
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.037
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.037
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.037
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.037
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.037
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.037
|
|
|
|
hypothalamic tangential migration using cell axon interactions
|
GO:0021856 |
3 |
0.037
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.037
|
|
|
|
negative regulation of synaptic vesicle transport
|
GO:1902804 |
3 |
0.036
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.036
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.036
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.036
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.036
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.035
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.035
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.035
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.035
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.035
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.035
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.034
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.034
|
|
|
|
sympathetic neuron projection extension
|
GO:0097490 |
4 |
0.034
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.034
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.034
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.034
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.034
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.034
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902043 |
13 |
0.034
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.033
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.033
|
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.033
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.033
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.033
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.033
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.033
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.033
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.033
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.033
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.033
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.032
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.032
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.032
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.032
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.032
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.032
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.031
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.031
|
|
|
|
sympathetic neuron projection guidance
|
GO:0097491 |
4 |
0.031
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.031
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.031
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.031
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.030
|
|
|
|
cerebral cortex tangential migration using cell axon interactions
|
GO:0021824 |
3 |
0.030
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.030
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.030
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.030
|
|
|
|
semaphorin plexin signaling pathway
|
GO:0071526 |
21 |
0.030
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.030
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.030
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.030
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.030
|
Human |
|
|
chromatin modification
|
GO:0016568 |
187 |
0.030
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.029
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.029
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.029
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.029
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.029
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.029
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.029
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.029
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.029
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.029
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.029
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.029
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.029
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.029
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.029
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.029
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.029
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.029
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.028
|
|
|
|
g protein coupled acetylcholine receptor signaling pathway
|
GO:0007213 |
4 |
0.028
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.028
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.028
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.028
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.028
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.028
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.028
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.028
|
|
|
|
vagus nerve development
|
GO:0021564 |
3 |
0.028
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.028
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.028
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.028
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.027
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.027
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.027
|
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.027
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.027
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.027
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.027
|
|
|
|
glossopharyngeal nerve morphogenesis
|
GO:0021615 |
4 |
0.027
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.027
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.027
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.026
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.026
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.026
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
26 |
0.026
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.026
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.026
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.026
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.026
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.026
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.026
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.026
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.026
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.026
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.026
|
|
|
|
detection of visible light
|
GO:0009584 |
14 |
0.026
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.026
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.026
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.026
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.026
|
|
|
|
positive regulation of extrinsic apoptotic signaling pathway
|
GO:2001238 |
34 |
0.026
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.026
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.026
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.026
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.025
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.025
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.025
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.025
|
|
|
|
dendritic spine maintenance
|
GO:0097062 |
4 |
0.025
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.025
|
Human |
|
|
golgi to endosome transport
|
GO:0006895 |
3 |
0.025
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.025
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.025
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.025
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.025
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.025
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.025
|
|
|
|
regulation of neuron migration
|
GO:2001222 |
22 |
0.025
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.025
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.025
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.025
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.024
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.024
|
|
|
|
cell aging
|
GO:0007569 |
35 |
0.024
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.024
|
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.024
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.024
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.024
|
Human |
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.024
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.024
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.024
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.024
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.024
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.024
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.024
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.024
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.024
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.024
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.024
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.024
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.024
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.024
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.024
|
|
|
|
positive regulation of apoptotic cell clearance
|
GO:2000427 |
3 |
0.023
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.023
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.023
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.023
|
|
|
|
substrate dependent cerebral cortex tangential migration
|
GO:0021825 |
3 |
0.023
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.023
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.023
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.023
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.023
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.023
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.023
|
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.023
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.023
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.023
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.023
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.023
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.023
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.023
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.022
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.022
|
|
|
|
hindbrain tangential cell migration
|
GO:0021934 |
2 |
0.022
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.022
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.022
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.022
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.022
|
Worm |
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.022
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.022
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.022
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.022
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.022
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.022
|
Human |
|
|
vagus nerve morphogenesis
|
GO:0021644 |
2 |
0.022
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.022
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.022
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.021
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.021
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.021
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.021
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.021
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.021
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.021
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.021
|
|
|
|
myelination in peripheral nervous system
|
GO:0022011 |
19 |
0.021
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.021
|
|
|
|
semaphorin plexin signaling pathway involved in axon guidance
|
GO:1902287 |
6 |
0.021
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.021
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.021
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.021
|
|
|
|
detection of light stimulus
|
GO:0009583 |
25 |
0.021
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.021
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.021
|
|
|
|
tumor necrosis factor ligand superfamily member 11 production
|
GO:0072535 |
1 |
0.021
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.021
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.021
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.020
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.020
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.020
|
|
|
|
cellular response to light stimulus
|
GO:0071482 |
19 |
0.020
|
|
|
|
microglia development
|
GO:0014005 |
2 |
0.020
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.020
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.020
|
|
|
|
mucopolysaccharide metabolic process
|
GO:1903510 |
25 |
0.020
|
|
|
|
activation of mapk activity involved in innate immune response
|
GO:0035419 |
2 |
0.020
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.020
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.020
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.020
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.020
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.020
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
58 |
0.020
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.020
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.020
|
|
